加载中
NYSEHealthcareMedical - Diagnostics & Research
最新数据
US$232.63
+US$1.66 · +0.72%
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
前收盘价
US$232.63
+US$1.66 · +0.72%
盘中时间采用ET。市场数据可能有所延迟。
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
日内区间
当前US$232.63
52周区间
当前US$232.63
盘中时间采用ET。市场数据可能有所延迟。
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
日内区间
当前US$232.63
52周区间
当前US$232.63
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$250
上涨空间 7.47%年度分割调整后的每股现金分配。
US$3.15
2025年（完整年度）+30.2% 自从 2021
2026年（部分年度）：US$3.38
US$2.42
2,021
US$3.26
2,022
US$2.79
2,023
US$2.96
2,024
US$3.15
2,025
US$3.38
2,026*
* 在现有股息历史记录中，该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年10月6日 | US$0.86Quarterly | 2026年10月6日 | 2026年10月21日 |
股息 | 2026年7月8日 | US$0.86Quarterly | 2026年7月8日 | 2026年7月22日 |
股息 | 2026年4月6日 | US$0.86Quarterly | 2026年4月6日 | 2026年4月20日 |
股息 | 2026年1月13日 | US$0.80Quarterly | 2026年1月13日 | 2026年1月28日 |
股息 | 2025年10月3日 | US$0.80Quarterly | 2025年10月3日 | 2025年10月20日 |
股息 | 2025年7月7日 | US$0.80Quarterly | 2025年7月7日 | 2025年7月21日 |
除息 2026年10月6日
US$0.86
Quarterly
2026年10月6日登记 · 支付日 2026年10月21日
除息 2026年7月8日
US$0.86
Quarterly
2026年7月8日登记 · 支付日 2026年7月22日
除息 2026年4月6日
US$0.86
Quarterly
2026年4月6日登记 · 支付日 2026年4月20日
除息 2026年1月13日
US$0.80
Quarterly
2026年1月13日登记 · 支付日 2026年1月28日
除息 2025年10月3日
US$0.80
Quarterly
2025年10月3日登记 · 支付日 2025年10月20日
除息 2025年7月7日
US$0.80
Quarterly
2025年7月7日登记 · 支付日 2025年7月21日
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T493.79亿0.04%129.43万亿 JPY0.09%JP¥123,000+0.12%
Vanguard Morningstar Total Stock Market ETFVTI8.45亿0.04%2.3万亿 USD0.03%US$381.57-0.10%
Vanguard S&P 500 ETFVOO7.07亿0.04%1.8万亿 USD0.03%US$715.13-0.06%
Vanguard Morningstar Mid-Cap ETFVO5.75亿0.25%2264亿 USD0.03%US$80.92-0.27%
iShares Core S&P 500 ETFIVV3.39亿0.04%8964.4亿 USD0.03%US$781.44-0.07%
State Street SPDR S&P 500 ETFSPY3.11亿0.04%8172亿 USD0.09%US$778.1-0.06%
Vanguard Morningstar Value ETFVTV2.54亿0.10%2624亿 USD0.03%US$221.43+0.38%
Invesco S&P 500 Equal Weight ETFRSP1.93亿0.20%977.83亿 USD0.20%US$213.19+0.07%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Mid-Cap ETFVOiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYVanguard Morningstar Value ETFVTVInvesco S&P 500 Equal Weight ETFRSPAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
